Home Oxazoles 104266-90-2
104266-90-2,MFCD09817644
Catalog No.:AA00861V

104266-90-2 | (S)-3-(3-Methylbutanoyl)-4-benzyloxazolidin-2-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$21.00   $15.00
- +
5g
95%
in stock  
$85.00   $60.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00861V
Chemical Name:
(S)-3-(3-Methylbutanoyl)-4-benzyloxazolidin-2-one
CAS Number:
104266-90-2
Molecular Formula:
C15H19NO3
Molecular Weight:
261.3163
MDL Number:
MFCD09817644
SMILES:
CC(CC(=O)N1C(=O)OC[C@@H]1Cc1ccccc1)C
Properties
Computed Properties
 
Complexity:
334  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
4  
XLogP3:
3  

Downstream Synthesis Route
503-74-2    90719-32-7   
(S)-4-benzyl-3-(3-methylbutanoyl)oxazolidin-2-one 

[1]Bessho,Yuki;Akaki,Tatsuo;Hara,Yoshinori;Yamakawa,Maki;Obika,Shingo;Mori,Genki;Ubukata,Minoru;Yasue,Katsutaka;Nakane,Yoshitomi;Terasako,Yasuo;Orita,Takuya;Doi,Satoki;Iwanaga,Tomoko;Fujishima,Ayumi;Adachi,Tsuyoshi;Ueno,Hiroshi;Motomura,Takahisa[BioorganicandMedicinalChemistry,2021,vol.52]

[2]Jiao,Zhi-Gang;Chang,Xiao-Wei;Ding,Wei;Liu,Guo-Jun;Song,Ke-Sheng;Zhu,Nian-Yong;Zhang,Dan-Wei;Yang,Dan[Chemistry-AnAsianJournal,2011,vol.6,#7,p.1791-1799]

[3]Evans,DavidA.;Ellman,JonA.;Dorow,RobertaL.[TetrahedronLetters,1987,vol.28,#11,p.1123-1126]

[1]Bradbury,RobertH.;Major,JohnS.;Oldham,AlecA.;Rivett,JanetE.;Roberts,DavidA.;etal.[JournalofMedicinalChemistry,1990,vol.33,#9,p.2335-2342]

[2]Bradbury,RobertH.;Revill,JohnM.;Rivett,JanetE.;Waterson,David[TetrahedronLetters,1989,vol.30,#29,p.3845-3848]

[3]CurrentPatentAssignee:ASTRAZENECAPLC-US5254697,1993,A

[1]Evans,DavidA.;Britton,ThomasC.;Ellman,JonathanA.;Dorow,RobertaL.[JournaloftheAmericanChemicalSociety,1990,vol.112,#10,p.4011-4030]

[2]Evans,DavidA.;Britton,ThomasC.;Ellman,JonathanA.;Dorow,RobertaL.[JournaloftheAmericanChemicalSociety,1990,vol.112,#10,p.4011-4030]

[1]Evans,DavidA.;Britton,ThomasC.[JournaloftheAmericanChemicalSociety,1987,vol.109,#22,p.6881-6883]

[2]Evans,DavidA.;Britton,ThomasC.;Ellman,JonathanA.;Dorow,RobertaL.[JournaloftheAmericanChemicalSociety,1990,vol.112,#10,p.4011-4030]

[3]Evans,DavidA.;Ellman,JonA.;Dorow,RobertaL.[TetrahedronLetters,1987,vol.28,#11,p.1123-1126]

[4]Evans,DavidA.;Britton,ThomasC.;Ellman,JonathanA.;Dorow,RobertaL.[JournaloftheAmericanChemicalSociety,1990,vol.112,#10,p.4011-4030]

[5]Evans,DavidA.;Britton,ThomasC.;Ellman,JonathanA.;Dorow,RobertaL.[JournaloftheAmericanChemicalSociety,1990,vol.112,#10,p.4011-4030]

[6]Evans,DavidA.;Britton,ThomasC.;Ellman,JonathanA.;Dorow,RobertaL.[JournaloftheAmericanChemicalSociety,1990,vol.112,#10,p.4011-4030]

90719-32-7    108-12-3   
(4S)-4-benzyl-3-(3-methylbutyryl)oxazolidin-2-one 

[1]Nam,Gyeok;Ko,SooY.[HelveticaChimicaActa,2012,vol.95,#10,p.1937-1945,9]

[2]CurrentPatentAssignee:GRUPOINSUD-WO2011/151442,2011,A2Locationinpatent:Page/Pagecolumn24

[3]CurrentPatentAssignee:GRUPOINSUD-US2013/71899,2013,A1Locationinpatent:Paragraph0124-0127

[4]Krimmer,StefanG.;Cramer,Jonathan;Betz,Michael;Fridh,Veronica;Karlsson,Robert;Heine,Andreas;Klebe,Gerhard[JournalofMedicinalChemistry,2016,vol.59,#23,p.10530-10548]

[5]CurrentPatentAssignee:HUNANHUATENGPHARMACEUTICALCOLTD-CN114315749,2022,ALocationinpatent:Paragraph0102-0104

[6]Pan,Xianhua;Xu,Siyao;Huang,Rui;Yu,Wansheng;Liu,Feng[OrganicProcessResearchandDevelopment,2015,vol.19,#6,p.611-617]

[7]Chen,Shu-Hui;Lamar,Jason;Guo,Deqi;Kohn,Todd;Yang,Hsiu-Chiung;McGee,James;Timm,David;Erickson,Jon;Yip,Yvonne;May,Patrick;McCarthy,James[BioorganicandMedicinalChemistryLetters,2004,vol.14,#1,p.245-250]

[8]Evans,DavidA.;Britton,ThomasC.;Dorow,RobertaL.;Dellaria,JosephF.[Tetrahedron,1988,vol.44,#17,p.5525-5540]

[9]CurrentPatentAssignee:VIMALANBIOSCIENCES-WO2020/227563,2020,A1Locationinpatent:Paragraph00223

[10]CurrentPatentAssignee:VIMALANBIOSCIENCES-WO2021/62036,2021,A1Locationinpatent:Paragraph00166

[11]Hanessian,Stephen;Guesne,Sebastien;Chenard,Etienne[OrganicLetters,2010,vol.12,#8,p.1816-1819]

[12]CurrentPatentAssignee:CHINANATIONALPHARMACEUTICALGROUPCORPORATION-CN102452994,2016,BLocationinpatent:Paragraph0030;0031

[13]CurrentPatentAssignee:KRKADDNOVOMESTO-EP2189442,2010,A1Locationinpatent:Page/Pagecolumn22;23

[14]Jakobsche,CharlesE.;Peris,Gorka;Miller,ScottJ.[AngewandteChemie-InternationalEdition,2008,vol.47,#35,p.6707-6711]

[15]Durham,TimothyB.;Marimuthu,Jothirajah;Toth,JamesL.;Liu,Chin;Adams,Lisa;Mudra,DanielR.;Swearingen,Craig;Lin,Chaohua;Chambers,MarkG.;Thirunavukkarasu,Kannan;Wiley,MichaelR.[JournalofMedicinalChemistry,2017,vol.60,#13,p.5933-5939]

[16]CurrentPatentAssignee:VIMALANBIOSCIENCES-WO2021/26465,2021,A1Locationinpatent:Paragraph00165

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:104266-90-2 Molecular Formula|104266-90-2 MDL|104266-90-2 SMILES|104266-90-2 (S)-3-(3-Methylbutanoyl)-4-benzyloxazolidin-2-one